Outlook Therapeutics (OTLK) Stock Price Target 2026

The average analyst price target for Outlook Therapeutics is $9.70, 1879.6% above the current price. Of 7 analysts, 4 rate it Buy and 3 Hold. Targets range from $1 to $31.40. The latest change came on Sep 11, 2026, when Ascendiant Capital raised its price target on Outlook Therapeutics from $10 to $10.50 and kept a Buy rating.